However, angiosarcoma tumor cells invariably show immunoreactivity for one or more endothelial markers (factor VIII, CD31, CD34; Fig. 9c–d), as well as epithelial markers such as cytokeratins and concomitant negativity for thyroglobulin or podoplanin (D240) [150]. This evidence concerns the gene PDPN and neoplasm.